First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Zhejiang University
Explore linked clinical trials.201 results ยท Page 1 of 9
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Sectional Study | Nutritional and Metabolic Diseases, nutritional deficiency disease, nutritional disorder, vitamin D deficiency, vitamin deficiency disorder | Enrolling by invitation | Not stated | 2026-10-08 | NCT07866391 | |
| Inebilizumab for the Treatment of Patients With Type 1 Autoimmune Pancreatitis | Chronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitis | Recruiting | Phase 4 | 2026-10-07 | NCT07862075 | |
| Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Recruiting | Not stated | 2026-10-07 | NCT07735182 | |
| A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of Recurrence | Chronic Disease, Digestive System Diseases, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Type 1 Autoimmune Pancreatitis, autoimmune disease, autoimmune pancreatitis, chronic pancreatitis, immune system disorder, pancreas disorder, pancreatitis | Recruiting | Phase 4 | 2026-10-06 | NCT06468709 | |
| Tobramycin Nebulization to Prevent Multidrug-Resistant Ventilator-Associated Pneumonia | Disease Attributes, Healthcare-Associated Pneumonia, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumonia, Ventilator-Associated, iatrogenic disease, lung disorder, nosocomial infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Phase 4 | 2026-10-02 | NCT07856355 | |
| Efgartigimod in Anti-NMDA Receptor Encephalitis. | Neoplasms by Site, Neuroinflammatory Diseases, Paraneoplastic Syndromes, Nervous System, anti-NMDA receptor encephalitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, encephalitis, immune system disorder, neoplasm, nervous system disorder, neurodegenerative disease, paraneoplastic syndrome | Recruiting | Phase 2 | 2026-09-16 | NCT07822776 | |
| Drug-coated Balloons Versus Drug-eluting Stents for the Treatment of Femoropopliteal In-Stent Restenosis | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Not yet recruiting | Not stated | 2026-09-16 | NCT07277218 | |
| 18F-S2P PET Imaging in the Evaluation of Large Artery Atherosclerosis | Embolism, Embolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder | Not yet recruiting | Not applicable | 2026-09-11 | NCT07815860 | |
| Safety and Efficacy of Ventricular Irrigation for Ventriculitis | Infections, central nervous system disorder, central nervous system infectious disorder, nervous system disorder | Recruiting | Not applicable | 2026-09-10 | NCT06358209 | |
| Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Not applicable | 2026-09-02 | NCT07183878 | |
| Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation | Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Not applicable | 2026-09-02 | NCT07003737 | |
| Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD | Belumosudil; Hematopoietic Stem Cell Transplantation (HSCT); Hepatic cGVHD; Ruxolitinib; cGVHD | Recruiting | Not applicable | 2026-08-31 | NCT07794514 | |
| Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection | Acute Aortic Syndrome, Aneurysm, Aortic Dissection, Dissection, Blood Vessel, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-31 | NCT06968806 | |
| GMPA Versus PPI for Gastric Protection and aGVHD Risk | Infections | Recruiting | Not applicable | 2026-08-28 | NCT07791849 | |
| SHR-A1811 Monotherapy or Sequential THPy as Neoadjuvant Therapy for Stage II-III HER2-Positive Breast Cancer | HER2-positive Breast Cancer | Not yet recruiting | Phase 2 | 2026-08-26 | NCT07787338 | |
| Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy | Cytopenia, Hemic and Lymphatic Diseases, blood platelet disease, hematologic disorder, thrombocytopenia, thrombotic microangiopathy | Recruiting | Not applicable | 2026-08-26 | NCT07347990 | |
| Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 3 | 2026-08-19 | NCT07774377 | |
| Video-guided Versus Conventional Right-sided Double-Lumen Tubes for One-Lung Ventilation in Thoracoscopic Surgery | Double Lumen Tube Intubation; One-Lung Ventilation; Thoracoscopic Surgery | Recruiting | Not applicable | 2026-08-17 | NCT07362797 | |
| An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-07-31 | NCT07153848 | |
| Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Enrolling by invitation | Not applicable | 2026-07-27 | NCT07694921 | |
| A Study on the Combination of Tongluo Huayu Formula in Treating RVO of Phlegm-Stasis Intertwinement Type: Based on the Mechanism of Systemic Metabolic Regulation Mediated by Gut Microbiota | Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder | Not yet recruiting | Not applicable | 2026-07-22 | NCT07718503 | |
| A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-07-21 | NCT05824923 | |
| Safety and Efficacy of Eculizumab in High-risk TA-TMA | Transplant-Associated Thrombotic Microangiopathy (TA-TMA) | Recruiting | Phase 2 | 2026-07-17 | NCT07707687 | |
| Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors | Healthy Allogeneic Hematopoietic Stem Cell Donor; Healthy Hematopoietic Stem Cell Donor | Recruiting | Phase 3 | 2026-07-15 | NCT07692841 | |
| Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD | graft versus host disease, immune system disorder | Recruiting | Not applicable | 2026-07-07 | NCT07184853 |